Invatec says trial backs drug-eluting balloon technology
This article was originally published in Clinica
Executive Summary
Invatec's drug-eluting balloon, IN.PACT Amphirion, has been shown to reduce restenosis by more than 50% when used to treat critical limb ischaemia (CLI) below the knee.